Clinical Performance of SARS-CoV-2 Molecular Testing Article Swipe
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1101/2020.05.06.20093575
Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the test clinical performance is poorly understood. From 3/10/2020-5/1/2020 NewYork-Presbyterian laboratories performed 27,377 SARS-CoV-2 molecular assays from 22,338 patients. Repeat testing was performed in 3,432 patients, of which 2,413 had negative and 1,019 had positive first day results. Repeat-tested patients were more likely to be older, male, African-American or Hispanic, and to have severe disease. Among the patients with initially negative results, 18.6% became positive upon repeat-testing. Only 58.1% of any-time positive patients had a result of “detected” on the first test. The clinical sensitivity of COVID-19 molecular assays is estimated between 66.2 % and 95.6%, depending on the unknown number of false negative results in single-tested patients. Conversion to a negative result is unlikely to occur before 15 to 20 days after initial testing or 20-30 days after the onset of symptoms, with 50% conversion occurring at 28 days after initial testing. Forty-nine initially-positive patients converted to negative and then back to positive in subsequent days. Conversion from first day negative to positive results increased linearly with each day of testing, reaching 25% probability in 20 days. In summary, our study provides estimates of the clinical performance of SARS-CoV-2 molecular assays and suggests time frames for appropriate repeat testing, namely 15 to 20 days after a positive test and the same or next 2 days after a negative test in a patient with high suspicion for COVID-19.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1101/2020.05.06.20093575
- https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdf
- OA Status
- green
- Cited By
- 2
- References
- 18
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3034809701
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3034809701Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1101/2020.05.06.20093575Digital Object Identifier
- Title
-
Clinical Performance of SARS-CoV-2 Molecular TestingWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-05-08Full publication date if available
- Authors
-
Daniel A. Green, Jason Zucker, Lars F. Westblade, Susan Whittier, Hanna Rennert, Priya Velu, Arryn Craney, Melissa M. Cushing, Dakai Liu, Magdalena E. Sobieszczyk, Amelia K. Boehme, Jorge L. SepulvedaList of authors in order
- Landing page
-
https://doi.org/10.1101/2020.05.06.20093575Publisher landing page
- PDF URL
-
https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdfDirect OA link when available
- Concepts
-
Medicine, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Gold standard (test), False Negative Reactions, Internal medicine, Coronavirus, Disease, Diagnostic test, Gastroenterology, Pediatrics, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2020: 2Per-year citation counts (last 5 years)
- References (count)
-
18Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3034809701 |
|---|---|
| doi | https://doi.org/10.1101/2020.05.06.20093575 |
| ids.doi | https://doi.org/10.1101/2020.05.06.20093575 |
| ids.mag | 3034809701 |
| ids.openalex | https://openalex.org/W3034809701 |
| fwci | 0.05737377 |
| type | preprint |
| title | Clinical Performance of SARS-CoV-2 Molecular Testing |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11754 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 detection and testing |
| topics[1].id | https://openalex.org/T10118 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9987000226974487 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[2].id | https://openalex.org/T10041 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9980999827384949 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | COVID-19 Clinical Research Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7287375926971436 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C3007834351 |
| concepts[1].level | 5 |
| concepts[1].score | 0.684093177318573 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[1].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[2].id | https://openalex.org/C3008058167 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6822866201400757 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[2].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[3].id | https://openalex.org/C40993552 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6124029159545898 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q514654 |
| concepts[3].display_name | Gold standard (test) |
| concepts[4].id | https://openalex.org/C2909814700 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5790513157844543 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q18207010 |
| concepts[4].display_name | False Negative Reactions |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5705989003181458 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2777648638 |
| concepts[6].level | 5 |
| concepts[6].score | 0.4186818301677704 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q57751738 |
| concepts[6].display_name | Coronavirus |
| concepts[7].id | https://openalex.org/C2779134260 |
| concepts[7].level | 2 |
| concepts[7].score | 0.416896790266037 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[7].display_name | Disease |
| concepts[8].id | https://openalex.org/C82157600 |
| concepts[8].level | 2 |
| concepts[8].score | 0.41379427909851074 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2671652 |
| concepts[8].display_name | Diagnostic test |
| concepts[9].id | https://openalex.org/C90924648 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3689839541912079 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[9].display_name | Gastroenterology |
| concepts[10].id | https://openalex.org/C187212893 |
| concepts[10].level | 1 |
| concepts[10].score | 0.193953275680542 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[10].display_name | Pediatrics |
| concepts[11].id | https://openalex.org/C524204448 |
| concepts[11].level | 3 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[11].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7287375926971436 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[1].score | 0.684093177318573 |
| keywords[1].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[2].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[2].score | 0.6822866201400757 |
| keywords[2].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[3].id | https://openalex.org/keywords/gold-standard |
| keywords[3].score | 0.6124029159545898 |
| keywords[3].display_name | Gold standard (test) |
| keywords[4].id | https://openalex.org/keywords/false-negative-reactions |
| keywords[4].score | 0.5790513157844543 |
| keywords[4].display_name | False Negative Reactions |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.5705989003181458 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/coronavirus |
| keywords[6].score | 0.4186818301677704 |
| keywords[6].display_name | Coronavirus |
| keywords[7].id | https://openalex.org/keywords/disease |
| keywords[7].score | 0.416896790266037 |
| keywords[7].display_name | Disease |
| keywords[8].id | https://openalex.org/keywords/diagnostic-test |
| keywords[8].score | 0.41379427909851074 |
| keywords[8].display_name | Diagnostic test |
| keywords[9].id | https://openalex.org/keywords/gastroenterology |
| keywords[9].score | 0.3689839541912079 |
| keywords[9].display_name | Gastroenterology |
| keywords[10].id | https://openalex.org/keywords/pediatrics |
| keywords[10].score | 0.193953275680542 |
| keywords[10].display_name | Pediatrics |
| language | en |
| locations[0].id | doi:10.1101/2020.05.06.20093575 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402567 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| locations[0].source.host_organization | https://openalex.org/I2750212522 |
| locations[0].source.host_organization_name | Cold Spring Harbor Laboratory |
| locations[0].source.host_organization_lineage | https://openalex.org/I2750212522 |
| locations[0].license | other-oa |
| locations[0].pdf_url | https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/other-oa |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1101/2020.05.06.20093575 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5043012643 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2394-1319 |
| authorships[0].author.display_name | Daniel A. Green |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2799503643 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY |
| authorships[0].institutions[0].id | https://openalex.org/I2799503643 |
| authorships[0].institutions[0].ror | https://ror.org/01esghr10 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2799503643 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Columbia University Irving Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Daniel A. Green |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY |
| authorships[1].author.id | https://openalex.org/A5012285335 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6987-6412 |
| authorships[1].author.display_name | Jason Zucker |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2799503643 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY |
| authorships[1].institutions[0].id | https://openalex.org/I2799503643 |
| authorships[1].institutions[0].ror | https://ror.org/01esghr10 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2799503643 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Columbia University Irving Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jason Zucker |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY |
| authorships[2].author.id | https://openalex.org/A5022980048 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3079-7674 |
| authorships[2].author.display_name | Lars F. Westblade |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[2].institutions[0].id | https://openalex.org/I205783295 |
| authorships[2].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Cornell University |
| authorships[2].institutions[1].id | https://openalex.org/I4387153466 |
| authorships[2].institutions[1].ror | https://ror.org/02r109517 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | Weill Cornell Medicine |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Lars F. Westblade |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[3].author.id | https://openalex.org/A5040332843 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Susan Whittier |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2799503643 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY |
| authorships[3].institutions[0].id | https://openalex.org/I2799503643 |
| authorships[3].institutions[0].ror | https://ror.org/01esghr10 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2799503643 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Columbia University Irving Medical Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Susan Whittier |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY |
| authorships[4].author.id | https://openalex.org/A5086545518 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1759-2562 |
| authorships[4].author.display_name | Hanna Rennert |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[4].institutions[0].id | https://openalex.org/I205783295 |
| authorships[4].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Cornell University |
| authorships[4].institutions[1].id | https://openalex.org/I4387153466 |
| authorships[4].institutions[1].ror | https://ror.org/02r109517 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | Weill Cornell Medicine |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Hanna Rennert |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[5].author.id | https://openalex.org/A5057391316 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1652-5971 |
| authorships[5].author.display_name | Priya Velu |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[5].institutions[0].id | https://openalex.org/I205783295 |
| authorships[5].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Cornell University |
| authorships[5].institutions[1].id | https://openalex.org/I4387153466 |
| authorships[5].institutions[1].ror | https://ror.org/02r109517 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | Weill Cornell Medicine |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Priya Velu |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[6].author.id | https://openalex.org/A5060885666 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0519-3628 |
| authorships[6].author.display_name | Arryn Craney |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[6].institutions[0].id | https://openalex.org/I205783295 |
| authorships[6].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Cornell University |
| authorships[6].institutions[1].id | https://openalex.org/I4387153466 |
| authorships[6].institutions[1].ror | https://ror.org/02r109517 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | Weill Cornell Medicine |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Arryn Craney |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[7].author.id | https://openalex.org/A5009054572 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8042-1494 |
| authorships[7].author.display_name | Melissa M. Cushing |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[7].institutions[0].id | https://openalex.org/I205783295 |
| authorships[7].institutions[0].ror | https://ror.org/05bnh6r87 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I205783295 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Cornell University |
| authorships[7].institutions[1].id | https://openalex.org/I4387153466 |
| authorships[7].institutions[1].ror | https://ror.org/02r109517 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I205783295, https://openalex.org/I4387153466 |
| authorships[7].institutions[1].country_code | US |
| authorships[7].institutions[1].display_name | Weill Cornell Medicine |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Melissa Cushing |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY |
| authorships[8].author.id | https://openalex.org/A5067453307 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-0658-5866 |
| authorships[8].author.display_name | Dakai Liu |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2801107848 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens Hospital |
| authorships[8].institutions[0].id | https://openalex.org/I2801107848 |
| authorships[8].institutions[0].ror | https://ror.org/01j17xg39 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2801107848 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | New York Hospital Queens |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Dakai Liu |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens Hospital |
| authorships[9].author.id | https://openalex.org/A5087375152 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-7112-3118 |
| authorships[9].author.display_name | Magdalena E. Sobieszczyk |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I2799503643 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY |
| authorships[9].institutions[0].id | https://openalex.org/I2799503643 |
| authorships[9].institutions[0].ror | https://ror.org/01esghr10 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I2799503643 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Columbia University Irving Medical Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Magdalena Sobieszczyk |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, NY |
| authorships[10].author.id | https://openalex.org/A5035161117 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-7408-1075 |
| authorships[10].author.display_name | Amelia K. Boehme |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2799503643 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Epidemiology and Neurology, Columbia University Irving Medical Center, New York, NY |
| authorships[10].institutions[0].id | https://openalex.org/I2799503643 |
| authorships[10].institutions[0].ror | https://ror.org/01esghr10 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2799503643 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Columbia University Irving Medical Center |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Amelia K. Boehme |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Epidemiology and Neurology, Columbia University Irving Medical Center, New York, NY |
| authorships[11].author.id | https://openalex.org/A5009268016 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5577-9766 |
| authorships[11].author.display_name | Jorge L. Sepulveda |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I2799503643 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY |
| authorships[11].institutions[0].id | https://openalex.org/I2799503643 |
| authorships[11].institutions[0].ror | https://ror.org/01esghr10 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I2799503643 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Columbia University Irving Medical Center |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Jorge L. Sepulveda |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Clinical Performance of SARS-CoV-2 Molecular Testing |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11754 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 detection and testing |
| related_works | https://openalex.org/W3020948716, https://openalex.org/W2484203845, https://openalex.org/W3002812395, https://openalex.org/W3047950519, https://openalex.org/W2768110043, https://openalex.org/W2523394474, https://openalex.org/W4281964270, https://openalex.org/W2112342754, https://openalex.org/W3169249739, https://openalex.org/W1573516605 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2020 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1101/2020.05.06.20093575 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402567 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| best_oa_location.source.host_organization | https://openalex.org/I2750212522 |
| best_oa_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1101/2020.05.06.20093575 |
| primary_location.id | doi:10.1101/2020.05.06.20093575 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402567 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| primary_location.source.host_organization | https://openalex.org/I2750212522 |
| primary_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| primary_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| primary_location.license | other-oa |
| primary_location.pdf_url | https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.05.06.20093575.full.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/other-oa |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1101/2020.05.06.20093575 |
| publication_date | 2020-05-08 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W3003217347, https://openalex.org/W3001897055, https://openalex.org/W3009885589, https://openalex.org/W3007497549, https://openalex.org/W3009318907, https://openalex.org/W3017813900, https://openalex.org/W4384764646, https://openalex.org/W3007928969, https://openalex.org/W3019218218, https://openalex.org/W3009567932, https://openalex.org/W3012956417, https://openalex.org/W3014802259, https://openalex.org/W3005363896, https://openalex.org/W2110065044, https://openalex.org/W3006110666, https://openalex.org/W1736775139, https://openalex.org/W2582743722, https://openalex.org/W3010233963 |
| referenced_works_count | 18 |
| abstract_inverted_index.% | 116 |
| abstract_inverted_index.2 | 9, 237 |
| abstract_inverted_index.a | 97, 133, 229, 240, 244 |
| abstract_inverted_index.15 | 141, 224 |
| abstract_inverted_index.20 | 143, 199, 226 |
| abstract_inverted_index.28 | 161 |
| abstract_inverted_index.In | 201 |
| abstract_inverted_index.at | 160 |
| abstract_inverted_index.be | 67 |
| abstract_inverted_index.in | 46, 128, 177, 198, 243 |
| abstract_inverted_index.is | 11, 27, 112, 136 |
| abstract_inverted_index.of | 17, 49, 92, 99, 108, 124, 154, 193, 207, 211 |
| abstract_inverted_index.on | 101, 120 |
| abstract_inverted_index.or | 71, 148, 235 |
| abstract_inverted_index.to | 66, 74, 132, 138, 142, 170, 175, 185, 225 |
| abstract_inverted_index.25% | 196 |
| abstract_inverted_index.50% | 157 |
| abstract_inverted_index.The | 105 |
| abstract_inverted_index.and | 54, 73, 117, 172, 215, 232 |
| abstract_inverted_index.but | 22 |
| abstract_inverted_index.day | 59, 183, 192 |
| abstract_inverted_index.for | 3, 15, 219, 249 |
| abstract_inverted_index.had | 52, 56, 96 |
| abstract_inverted_index.our | 203 |
| abstract_inverted_index.the | 12, 23, 79, 102, 121, 152, 208, 233 |
| abstract_inverted_index.was | 44 |
| abstract_inverted_index.2019 | 20 |
| abstract_inverted_index.66.2 | 115 |
| abstract_inverted_index.From | 30 |
| abstract_inverted_index.Only | 90 |
| abstract_inverted_index.back | 174 |
| abstract_inverted_index.days | 144, 150, 162, 227, 238 |
| abstract_inverted_index.each | 191 |
| abstract_inverted_index.from | 39, 181 |
| abstract_inverted_index.gold | 13 |
| abstract_inverted_index.have | 75 |
| abstract_inverted_index.high | 247 |
| abstract_inverted_index.more | 64 |
| abstract_inverted_index.next | 236 |
| abstract_inverted_index.same | 234 |
| abstract_inverted_index.test | 24, 231, 242 |
| abstract_inverted_index.then | 173 |
| abstract_inverted_index.time | 217 |
| abstract_inverted_index.upon | 88 |
| abstract_inverted_index.were | 63 |
| abstract_inverted_index.with | 81, 156, 190, 246 |
| abstract_inverted_index.1,019 | 55 |
| abstract_inverted_index.18.6% | 85 |
| abstract_inverted_index.2,413 | 51 |
| abstract_inverted_index.20-30 | 149 |
| abstract_inverted_index.3,432 | 47 |
| abstract_inverted_index.58.1% | 91 |
| abstract_inverted_index.Among | 78 |
| abstract_inverted_index.acute | 5 |
| abstract_inverted_index.after | 145, 151, 163, 228, 239 |
| abstract_inverted_index.days. | 179, 200 |
| abstract_inverted_index.false | 125 |
| abstract_inverted_index.first | 58, 103, 182 |
| abstract_inverted_index.male, | 69 |
| abstract_inverted_index.occur | 139 |
| abstract_inverted_index.onset | 153 |
| abstract_inverted_index.study | 204 |
| abstract_inverted_index.test. | 104 |
| abstract_inverted_index.which | 50 |
| abstract_inverted_index.22,338 | 40 |
| abstract_inverted_index.27,377 | 35 |
| abstract_inverted_index.95.6%, | 118 |
| abstract_inverted_index.Repeat | 42 |
| abstract_inverted_index.assays | 38, 111, 214 |
| abstract_inverted_index.became | 86 |
| abstract_inverted_index.before | 140 |
| abstract_inverted_index.frames | 218 |
| abstract_inverted_index.likely | 65 |
| abstract_inverted_index.namely | 223 |
| abstract_inverted_index.number | 123 |
| abstract_inverted_index.older, | 68 |
| abstract_inverted_index.poorly | 28 |
| abstract_inverted_index.repeat | 221 |
| abstract_inverted_index.result | 98, 135 |
| abstract_inverted_index.severe | 4, 76 |
| abstract_inverted_index.between | 114 |
| abstract_inverted_index.disease | 19 |
| abstract_inverted_index.initial | 146, 164 |
| abstract_inverted_index.patient | 245 |
| abstract_inverted_index.results | 127, 187 |
| abstract_inverted_index.testing | 2, 43, 147 |
| abstract_inverted_index.unknown | 122 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.COVID-19 | 109 |
| abstract_inverted_index.any-time | 93 |
| abstract_inverted_index.clinical | 25, 106, 209 |
| abstract_inverted_index.disease. | 77 |
| abstract_inverted_index.linearly | 189 |
| abstract_inverted_index.negative | 53, 83, 126, 134, 171, 184, 241 |
| abstract_inverted_index.patients | 62, 80, 95, 168 |
| abstract_inverted_index.positive | 57, 87, 94, 176, 186, 230 |
| abstract_inverted_index.provides | 205 |
| abstract_inverted_index.reaching | 195 |
| abstract_inverted_index.results, | 84 |
| abstract_inverted_index.results. | 60 |
| abstract_inverted_index.standard | 14 |
| abstract_inverted_index.suggests | 216 |
| abstract_inverted_index.summary, | 202 |
| abstract_inverted_index.syndrome | 7 |
| abstract_inverted_index.testing, | 194, 222 |
| abstract_inverted_index.testing. | 165 |
| abstract_inverted_index.unlikely | 137 |
| abstract_inverted_index.COVID-19. | 250 |
| abstract_inverted_index.Hispanic, | 72 |
| abstract_inverted_index.Molecular | 1 |
| abstract_inverted_index.converted | 169 |
| abstract_inverted_index.depending | 119 |
| abstract_inverted_index.diagnosis | 16 |
| abstract_inverted_index.estimated | 113 |
| abstract_inverted_index.estimates | 206 |
| abstract_inverted_index.increased | 188 |
| abstract_inverted_index.initially | 82 |
| abstract_inverted_index.molecular | 37, 110, 213 |
| abstract_inverted_index.occurring | 159 |
| abstract_inverted_index.patients, | 48 |
| abstract_inverted_index.patients. | 41, 130 |
| abstract_inverted_index.performed | 34, 45 |
| abstract_inverted_index.suspicion | 248 |
| abstract_inverted_index.symptoms, | 155 |
| abstract_inverted_index.Conversion | 131, 180 |
| abstract_inverted_index.Forty-nine | 166 |
| abstract_inverted_index.SARS-CoV-2 | 36, 212 |
| abstract_inverted_index.conversion | 158 |
| abstract_inverted_index.subsequent | 178 |
| abstract_inverted_index.(COVID-19), | 21 |
| abstract_inverted_index.appropriate | 220 |
| abstract_inverted_index.coronavirus | 8, 18 |
| abstract_inverted_index.performance | 26, 210 |
| abstract_inverted_index.probability | 197 |
| abstract_inverted_index.respiratory | 6 |
| abstract_inverted_index.sensitivity | 107 |
| abstract_inverted_index.understood. | 29 |
| abstract_inverted_index.(SARS-CoV-2) | 10 |
| abstract_inverted_index.laboratories | 33 |
| abstract_inverted_index.Repeat-tested | 61 |
| abstract_inverted_index.single-tested | 129 |
| abstract_inverted_index.“detected” | 100 |
| abstract_inverted_index.repeat-testing. | 89 |
| abstract_inverted_index.African-American | 70 |
| abstract_inverted_index.3/10/2020-5/1/2020 | 31 |
| abstract_inverted_index.initially-positive | 167 |
| abstract_inverted_index.NewYork-Presbyterian | 32 |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5009268016 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I2799503643 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8399999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.45096263 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |